Overview

Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS

Status:
Recruiting
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
Comparison of Neobianacid® clinical efficacy to omeprazole in relief of heartburn or epigastric pain
Phase:
Phase 4
Details
Lead Sponsor:
Aboca Spa Societa' Agricola
Collaborators:
BMR Genomics
Doppel Farmaceutici
Sprim Advanced Life Sciences
University of Roma La Sapienza
Treatments:
Omeprazole